These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6130595

  • 21. Prazosin: a review of clinical experience in hypertension.
    Packard RS.
    Ther Umsch; 1981; 38 Suppl():28-32. PubMed ID: 6122285
    [No Abstract] [Full Text] [Related]

  • 22. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL, Metcalfe J, Simpson CN.
    Br Med J (Clin Res Ed); 1982 Apr 17; 284(6323):1145-8. PubMed ID: 6122483
    [Abstract] [Full Text] [Related]

  • 23. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Apr 17; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 24. [Serum high density lipoprotein cholesterol in a population of asymptomatic men in Santiago, Chile].
    Arteaga A, Maiz A, Donoso V, Aravena M, Acosta AM.
    Rev Med Chil; 1983 Feb 17; 111(2):115-23. PubMed ID: 6580687
    [No Abstract] [Full Text] [Related]

  • 25. The effect of nifedipine on plasma lipids in patients with essential hypertension.
    Lehtonen A, Tanskanen A, Lehto H, Jarvensiven P.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul 17; 24(7):357-8. PubMed ID: 3460970
    [Abstract] [Full Text] [Related]

  • 26. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M, Carzaniga G, Garimoldi M, Sala R, Castelfranco M, Libretti A.
    G Ital Cardiol; 1981 Jul 17; 11(12):1944-7. PubMed ID: 7346295
    [Abstract] [Full Text] [Related]

  • 27. [Vitamin E megadoses and their effect on HDL cholesterol levels in patients with atherosclerotic complications (author's transl)].
    Turay J, Beseda I, Michalcová A.
    Cas Lek Cesk; 1981 Dec 03; 120(48):1432-4. PubMed ID: 6947861
    [No Abstract] [Full Text] [Related]

  • 28. [Levels of LDL-cholesterol, HDL-cholesterol and VLDL-cholesterol in umbilical cord blood and sera of healthy adults].
    Zhang HZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec 03; 11(4):246-8. PubMed ID: 6585286
    [No Abstract] [Full Text] [Related]

  • 29. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec 03; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 30. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L, Karádi I, Rozenberczki M, Kammerer L.
    Acta Med Acad Sci Hung; 1982 Dec 03; 39(3-4):117-23. PubMed ID: 6764327
    [Abstract] [Full Text] [Related]

  • 31. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
    Miyake N, Iizuka K.
    Rinsho Byori; 2002 Jun 03; 50(6):605-12. PubMed ID: 12166081
    [Abstract] [Full Text] [Related]

  • 32. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I, Pometta D, Micheli H, Raymond L.
    Helv Paediatr Acta; 1981 Jun 03; 36(2):135-47. PubMed ID: 7251385
    [Abstract] [Full Text] [Related]

  • 33. Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Maiwald C.
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec 03; 26(12):597-604. PubMed ID: 2905341
    [Abstract] [Full Text] [Related]

  • 34. Serum lipoprotein changes during atenolol treatment of essential hypertension.
    Eliasson K, Lins LE, Rössner S.
    Eur J Clin Pharmacol; 1981 Dec 03; 20(5):335-8. PubMed ID: 7286043
    [Abstract] [Full Text] [Related]

  • 35. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A, Tanskanen A, Temmerman J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug 03; 25(8):448-51. PubMed ID: 2888737
    [Abstract] [Full Text] [Related]

  • 36. HDL-cholesterol (HDL-C) changes during and after intensive long-lasting exercise.
    Berg A, Johns J, Baumstark M, Keul J.
    Int J Sports Med; 1981 May 03; 2(2):121-3. PubMed ID: 6949879
    [No Abstract] [Full Text] [Related]

  • 37. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
    Farsang C, Péter M, Balás-Eltes A, Fehér J.
    J Cardiovasc Pharmacol; 1987 May 03; 10 Suppl 12():S240-3. PubMed ID: 2455187
    [Abstract] [Full Text] [Related]

  • 38. [On the importance of new test of HDL-cholesterol in lipoid diagnostics with geriatric patients (author's transl)].
    Braun M.
    Aktuelle Gerontol; 1982 Mar 03; 12(2):50-3. PubMed ID: 6123271
    [Abstract] [Full Text] [Related]

  • 39. The effects of labetalol and oxprenolol on blood lipids.
    Sommers DK, de Villiers LS, van Wyk M, Schoeman HS.
    S Afr Med J; 1981 Sep 05; 60(10):379-80. PubMed ID: 7025257
    [Abstract] [Full Text] [Related]

  • 40. Effect of beta-blockers on plasma lipids.
    Pasotti C, Zoppi A, Capra A, Rebagliati M, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug 05; 24(8):448-52. PubMed ID: 3759280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.